

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | blood coagulation, intrinsic pathway (GO:0007597) | 6.49736234 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.27694988 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 6.07643489 |
| 4 | protein neddylation (GO:0045116) | 5.71024226 |
| 5 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.44520488 |
| 6 | regulation of platelet activation (GO:0010543) | 5.21442639 |
| 7 | regulation of platelet aggregation (GO:0090330) | 4.95571038 |
| 8 | angiogenesis involved in wound healing (GO:0060055) | 4.74645601 |
| 9 | negative regulation of platelet activation (GO:0010544) | 4.66372865 |
| 10 | platelet aggregation (GO:0070527) | 4.64084366 |
| 11 | adenosine receptor signaling pathway (GO:0001973) | 4.45792249 |
| 12 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.38332263 |
| 13 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.33298786 |
| 14 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.24828957 |
| 15 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.22182034 |
| 16 | negative regulation of norepinephrine secretion (GO:0010700) | 4.21033126 |
| 17 | platelet degranulation (GO:0002576) | 4.07814839 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.05110492 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 4.05110492 |
| 20 | positive regulation of blood coagulation (GO:0030194) | 4.04273429 |
| 21 | positive regulation of hemostasis (GO:1900048) | 4.04273429 |
| 22 | lipoxygenase pathway (GO:0019372) | 3.96732702 |
| 23 | neutrophil activation (GO:0042119) | 3.83645110 |
| 24 | regulation of integrin activation (GO:0033623) | 3.82848430 |
| 25 | positive regulation of receptor recycling (GO:0001921) | 3.71377149 |
| 26 | positive regulation of coagulation (GO:0050820) | 3.61876201 |
| 27 | endothelium development (GO:0003158) | 3.60565942 |
| 28 | negative regulation of blood coagulation (GO:0030195) | 3.58585725 |
| 29 | negative regulation of hemostasis (GO:1900047) | 3.58585725 |
| 30 | negative regulation of heart rate (GO:0010459) | 3.50523272 |
| 31 | platelet activation (GO:0030168) | 3.49248705 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.49026682 |
| 33 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.48931486 |
| 34 | megakaryocyte development (GO:0035855) | 3.47969857 |
| 35 | regulation of lipoprotein metabolic process (GO:0050746) | 3.47851357 |
| 36 | L-phenylalanine metabolic process (GO:0006558) | 3.39329171 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.39329171 |
| 38 | regulation of hemostasis (GO:1900046) | 3.39150708 |
| 39 | regulation of blood coagulation (GO:0030193) | 3.39150708 |
| 40 | granulocyte activation (GO:0036230) | 3.38268523 |
| 41 | fibrinolysis (GO:0042730) | 3.37870621 |
| 42 | platelet formation (GO:0030220) | 3.36098523 |
| 43 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.35111681 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34413827 |
| 45 | negative regulation of coagulation (GO:0050819) | 3.27585595 |
| 46 | positive regulation of macrophage differentiation (GO:0045651) | 3.25347557 |
| 47 | homotypic cell-cell adhesion (GO:0034109) | 3.24590927 |
| 48 | tyrosine metabolic process (GO:0006570) | 3.23747175 |
| 49 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.18047491 |
| 50 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.15000425 |
| 51 | regulation of endothelial cell differentiation (GO:0045601) | 3.12524352 |
| 52 | regulation of coagulation (GO:0050818) | 3.11158464 |
| 53 | extracellular fibril organization (GO:0043206) | 3.08195104 |
| 54 | * triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.03284009 |
| 55 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.02524204 |
| 56 | peptide catabolic process (GO:0043171) | 3.02222806 |
| 57 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.01864883 |
| 58 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.96515615 |
| 59 | negative regulation of protein localization to cell surface (GO:2000009) | 2.95660133 |
| 60 | superoxide anion generation (GO:0042554) | 2.95572747 |
| 61 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.94833766 |
| 62 | beta-amyloid metabolic process (GO:0050435) | 2.93900628 |
| 63 | protein activation cascade (GO:0072376) | 2.93797205 |
| 64 | negative regulation of wound healing (GO:0061045) | 2.92499127 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90462693 |
| 66 | purinergic receptor signaling pathway (GO:0035587) | 2.88849089 |
| 67 | regulation of norepinephrine secretion (GO:0014061) | 2.88702029 |
| 68 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.86043069 |
| 69 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.84915006 |
| 70 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.83865431 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.83213239 |
| 72 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.82584634 |
| 73 | regulation of receptor recycling (GO:0001919) | 2.81725233 |
| 74 | negative regulation of T cell apoptotic process (GO:0070233) | 2.79539513 |
| 75 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.78889404 |
| 76 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.76510726 |
| 77 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.74984269 |
| 78 | protein carboxylation (GO:0018214) | 2.74984269 |
| 79 | fibril organization (GO:0097435) | 2.74698928 |
| 80 | negative regulation of appetite (GO:0032099) | 2.73200277 |
| 81 | negative regulation of response to food (GO:0032096) | 2.73200277 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72813420 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71407800 |
| 84 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71407800 |
| 85 | leukocyte degranulation (GO:0043299) | 2.69961982 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69160094 |
| 87 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.68370726 |
| 88 | positive regulation of B cell mediated immunity (GO:0002714) | 2.68370726 |
| 89 | regulation of mast cell activation (GO:0033003) | 2.66134088 |
| 90 | negative regulation of focal adhesion assembly (GO:0051895) | 2.62719185 |
| 91 | negative regulation of cell junction assembly (GO:1901889) | 2.62719185 |
| 92 | negative regulation of adherens junction organization (GO:1903392) | 2.62719185 |
| 93 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.59861883 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.56133165 |
| 95 | positive regulation of wound healing (GO:0090303) | 2.56016341 |
| 96 | polyamine biosynthetic process (GO:0006596) | 2.55930538 |
| 97 | termination of signal transduction (GO:0023021) | 2.55400389 |
| 98 | regulation of cholesterol esterification (GO:0010872) | 2.55286058 |
| 99 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.54491545 |
| 100 | negative regulation of stress fiber assembly (GO:0051497) | 2.52757609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.24007337 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.88623626 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.72150425 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49122986 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.43377196 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03106752 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.87546074 |
| 8 | GATA1_19941826_ChIP-Seq_K562_Human | 2.86705633 |
| 9 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.77399941 |
| 10 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.77338999 |
| 11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.72020856 |
| 12 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.60373719 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.59202706 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.57161261 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41297596 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.35118901 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.34400480 |
| 18 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.32858598 |
| 19 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.32773320 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.32124692 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 2.31743806 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25005021 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24738732 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18313828 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17874798 |
| 26 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.17538159 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12755133 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01300202 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.97302438 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97246037 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.94969382 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88592955 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77361605 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75187203 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72233320 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61534969 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58141256 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.55153959 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54557882 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53335305 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52910687 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48973502 |
| 43 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.47439653 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47343003 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46719155 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44085280 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43271023 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42685417 |
| 49 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.35867731 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33354622 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31908030 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31751849 |
| 53 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.29097635 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28835044 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28833386 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26943656 |
| 57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.25174935 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23634339 |
| 59 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.21067849 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20954495 |
| 61 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19912699 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18305995 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17051254 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.12153387 |
| 65 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07527050 |
| 66 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06419312 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05990013 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05932504 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.05923111 |
| 70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02010753 |
| 71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01193684 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01089178 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00203940 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 0.99687566 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98309219 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97077234 |
| 77 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95250692 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94911910 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94637455 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94261908 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94020516 |
| 82 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93381888 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92465900 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90034354 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89422165 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88273485 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87516944 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85847265 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84609449 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83667799 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83252887 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82203043 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82203043 |
| 94 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81897358 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81584023 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80372282 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80314438 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79847229 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 0.79707118 |
| 100 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79291970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 7.88821351 |
| 2 | MP0003724_increased_susceptibility_to | 4.11282292 |
| 3 | MP0008004_abnormal_stomach_pH | 3.84714098 |
| 4 | MP0003303_peritoneal_inflammation | 3.32920463 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.24960490 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.83735997 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.68028434 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.46035996 |
| 9 | MP0004510_myositis | 2.21587752 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.16623099 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.15934907 |
| 12 | MP0000343_altered_response_to | 2.13359346 |
| 13 | MP0005671_abnormal_response_to | 2.11228145 |
| 14 | MP0010368_abnormal_lymphatic_system | 2.09946601 |
| 15 | MP0005000_abnormal_immune_tolerance | 1.93823415 |
| 16 | MP0000685_abnormal_immune_system | 1.92721385 |
| 17 | MP0003436_decreased_susceptibility_to | 1.88886034 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 1.82264429 |
| 19 | MP0010155_abnormal_intestine_physiology | 1.81463802 |
| 20 | MP0003828_pulmonary_edema | 1.79428971 |
| 21 | MP0001800_abnormal_humoral_immune | 1.77841589 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.73356994 |
| 23 | MP0005083_abnormal_biliary_tract | 1.68406495 |
| 24 | MP0002132_abnormal_respiratory_system | 1.62883007 |
| 25 | MP0002398_abnormal_bone_marrow | 1.59929014 |
| 26 | MP0001790_abnormal_immune_system | 1.59139064 |
| 27 | MP0005387_immune_system_phenotype | 1.59139064 |
| 28 | MP0000230_abnormal_systemic_arterial | 1.58557210 |
| 29 | MP0005025_abnormal_response_to | 1.57503302 |
| 30 | MP0002723_abnormal_immune_serum | 1.57431527 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.57110410 |
| 32 | MP0003638_abnormal_response/metabolism_ | 1.54365831 |
| 33 | MP0001851_eye_inflammation | 1.54298726 |
| 34 | MP0000249_abnormal_blood_vessel | 1.54196651 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.49059991 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.45161865 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.44544857 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.43548383 |
| 39 | MP0002419_abnormal_innate_immunity | 1.42326333 |
| 40 | MP0009785_altered_susceptibility_to | 1.37757560 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.35740817 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.35719235 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.35108344 |
| 44 | MP0005365_abnormal_bile_salt | 1.33976791 |
| 45 | MP0001819_abnormal_immune_cell | 1.33869566 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.33331635 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.33331635 |
| 48 | MP0009763_increased_sensitivity_to | 1.33105484 |
| 49 | MP0004947_skin_inflammation | 1.29326914 |
| 50 | MP0004130_abnormal_muscle_cell | 1.27802972 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.26929146 |
| 52 | MP0009764_decreased_sensitivity_to | 1.25733297 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.24586716 |
| 54 | MP0002429_abnormal_blood_cell | 1.21638014 |
| 55 | MP0003879_abnormal_hair_cell | 1.20953510 |
| 56 | MP0001663_abnormal_digestive_system | 1.20295882 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.20013786 |
| 58 | MP0000858_altered_metastatic_potential | 1.18957452 |
| 59 | MP0000716_abnormal_immune_system | 1.18379974 |
| 60 | MP0008872_abnormal_physiological_respon | 1.15623774 |
| 61 | MP0004084_abnormal_cardiac_muscle | 1.14389566 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.13448538 |
| 63 | MP0008874_decreased_physiological_sensi | 1.12700774 |
| 64 | MP0005410_abnormal_fertilization | 1.12355051 |
| 65 | MP0002722_abnormal_immune_system | 1.11680119 |
| 66 | MP0009697_abnormal_copulation | 1.10341813 |
| 67 | MP0003866_abnormal_defecation | 1.01916363 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.01786732 |
| 69 | MP0008260_abnormal_autophagy | 1.00200267 |
| 70 | MP0009642_abnormal_blood_homeostasis | 0.99036145 |
| 71 | MP0006054_spinal_hemorrhage | 0.97972612 |
| 72 | MP0003011_delayed_dark_adaptation | 0.97256389 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97096620 |
| 74 | MP0002736_abnormal_nociception_after | 0.96684272 |
| 75 | MP0003075_altered_response_to | 0.95937293 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.95698135 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 0.91938292 |
| 78 | MP0004036_abnormal_muscle_relaxation | 0.91051533 |
| 79 | MP0005360_urolithiasis | 0.89377351 |
| 80 | MP0005165_increased_susceptibility_to | 0.88652688 |
| 81 | MP0003763_abnormal_thymus_physiology | 0.85181105 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.83313312 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.82643501 |
| 84 | MP0009840_abnormal_foam_cell | 0.82344006 |
| 85 | MP0005535_abnormal_body_temperature | 0.79741668 |
| 86 | MP0004883_abnormal_blood_vessel | 0.79622495 |
| 87 | MP0003186_abnormal_redox_activity | 0.78643839 |
| 88 | MP0005023_abnormal_wound_healing | 0.77575392 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.76664862 |
| 90 | MP0002405_respiratory_system_inflammati | 0.76265185 |
| 91 | MP0008469_abnormal_protein_level | 0.71344194 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.71069122 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.70656679 |
| 94 | MP0004272_abnormal_basement_membrane | 0.69893041 |
| 95 | MP0002128_abnormal_blood_circulation | 0.69638739 |
| 96 | MP0003091_abnormal_cell_migration | 0.68767104 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.68606973 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.68293682 |
| 99 | MP0003252_abnormal_bile_duct | 0.66418149 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.66057844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Menorrhagia (HP:0000132) | 9.47000182 |
| 2 | Increased mean platelet volume (HP:0011877) | 8.85169272 |
| 3 | Abnormal platelet volume (HP:0011876) | 8.50272059 |
| 4 | Purpura (HP:0000979) | 8.37453054 |
| 5 | Petechiae (HP:0000967) | 7.95218162 |
| 6 | Epistaxis (HP:0000421) | 7.14949595 |
| 7 | Gingival bleeding (HP:0000225) | 6.09494315 |
| 8 | Spontaneous hematomas (HP:0007420) | 5.27206767 |
| 9 | Impaired platelet aggregation (HP:0003540) | 4.99583891 |
| 10 | Abnormal platelet function (HP:0011869) | 4.99583891 |
| 11 | Conjunctival telangiectasia (HP:0000524) | 3.93665090 |
| 12 | Poikilocytosis (HP:0004447) | 3.92609814 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88374394 |
| 14 | Joint hemorrhage (HP:0005261) | 3.86976220 |
| 15 | Acanthocytosis (HP:0001927) | 3.68303040 |
| 16 | Xanthomatosis (HP:0000991) | 3.48386835 |
| 17 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.47939918 |
| 18 | Dyschromatopsia (HP:0007641) | 3.34741147 |
| 19 | * Hyperlipoproteinemia (HP:0010980) | 3.33479187 |
| 20 | Abnormal pupillary function (HP:0007686) | 3.30839147 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.26336998 |
| 22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.13416643 |
| 23 | Paralysis (HP:0003470) | 3.10689424 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.05517961 |
| 25 | Bruising susceptibility (HP:0000978) | 3.03303753 |
| 26 | Joint swelling (HP:0001386) | 2.95658817 |
| 27 | Abnormality of lateral ventricle (HP:0030047) | 2.85464505 |
| 28 | Complement deficiency (HP:0004431) | 2.80054876 |
| 29 | Increased IgM level (HP:0003496) | 2.77886542 |
| 30 | Polycythemia (HP:0001901) | 2.71665734 |
| 31 | Eczematoid dermatitis (HP:0000976) | 2.66566557 |
| 32 | Hepatosplenomegaly (HP:0001433) | 2.61207580 |
| 33 | Abnormality of complement system (HP:0005339) | 2.61115114 |
| 34 | Abnormality of iron homeostasis (HP:0011031) | 2.53985755 |
| 35 | Obstructive lung disease (HP:0006536) | 2.52699108 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52699108 |
| 37 | Spontaneous abortion (HP:0005268) | 2.44789381 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39650257 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.39614504 |
| 40 | Increased density of long bones (HP:0006392) | 2.37582033 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32683174 |
| 42 | Decreased central vision (HP:0007663) | 2.29234560 |
| 43 | Thrombophlebitis (HP:0004418) | 2.27757549 |
| 44 | Stomatitis (HP:0010280) | 2.27686801 |
| 45 | Hemorrhage of the eye (HP:0011885) | 2.27529317 |
| 46 | Encephalitis (HP:0002383) | 2.26201353 |
| 47 | Myocardial infarction (HP:0001658) | 2.25123738 |
| 48 | Glomerulonephritis (HP:0000099) | 2.22515000 |
| 49 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17939089 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.15381032 |
| 51 | Arterial thrombosis (HP:0004420) | 2.13505587 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.13466585 |
| 53 | Increased serum ferritin (HP:0003281) | 2.11851497 |
| 54 | Pulmonary embolism (HP:0002204) | 2.07701176 |
| 55 | Nausea (HP:0002018) | 2.05744271 |
| 56 | Upper limb muscle weakness (HP:0003484) | 2.04924632 |
| 57 | Abnormal auditory evoked potentials (HP:0006958) | 2.04298104 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.03738193 |
| 59 | Vasculitis (HP:0002633) | 2.02339759 |
| 60 | Prolonged bleeding time (HP:0003010) | 10.0549386 |
| 61 | Meningitis (HP:0001287) | 1.98715653 |
| 62 | Prolonged partial thromboplastin time (HP:0003645) | 1.95618446 |
| 63 | IgA deficiency (HP:0002720) | 1.94260932 |
| 64 | Recurrent abscess formation (HP:0002722) | 1.92717437 |
| 65 | Hypertriglyceridemia (HP:0002155) | 1.88777230 |
| 66 | Mucosal telangiectasiae (HP:0100579) | 1.85109041 |
| 67 | Nephritis (HP:0000123) | 1.81961038 |
| 68 | Inflammation of the large intestine (HP:0002037) | 1.80334084 |
| 69 | Microcytic anemia (HP:0001935) | 1.80182213 |
| 70 | Abnormality of the prostate (HP:0008775) | 1.79709925 |
| 71 | Hypophosphatemic rickets (HP:0004912) | 1.78032959 |
| 72 | Episodic fever (HP:0001954) | 1.72184733 |
| 73 | Arthralgia (HP:0002829) | 1.71692856 |
| 74 | Dysostosis multiplex (HP:0000943) | 1.69748032 |
| 75 | Mitral stenosis (HP:0001718) | 1.69611446 |
| 76 | Cerebral hemorrhage (HP:0001342) | 1.69567747 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 1.68048266 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 1.64433857 |
| 79 | Vertigo (HP:0002321) | 1.63899796 |
| 80 | Dysautonomia (HP:0002459) | 1.63735536 |
| 81 | Basal ganglia calcification (HP:0002135) | 1.63591214 |
| 82 | Recurrent bacterial skin infections (HP:0005406) | 1.63124380 |
| 83 | Emphysema (HP:0002097) | 1.62258517 |
| 84 | Male infertility (HP:0003251) | 1.62044544 |
| 85 | Chest pain (HP:0100749) | 1.61905186 |
| 86 | Muscle fibrillation (HP:0010546) | 1.59695411 |
| 87 | Tinnitus (HP:0000360) | 1.57571845 |
| 88 | Thyroid-stimulating hormone excess (HP:0002925) | 1.56782106 |
| 89 | Recurrent sinusitis (HP:0011108) | 1.55389534 |
| 90 | Testicular neoplasm (HP:0010788) | 1.54324537 |
| 91 | Cellulitis (HP:0100658) | 1.51709009 |
| 92 | Cerebral ischemia (HP:0002637) | 1.51337957 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.51253673 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.49736879 |
| 95 | Acute hepatic failure (HP:0006554) | 1.47381415 |
| 96 | Retrobulbar optic neuritis (HP:0100654) | 1.46817303 |
| 97 | Optic neuritis (HP:0100653) | 1.46817303 |
| 98 | Hypochromic microcytic anemia (HP:0004840) | 1.46297705 |
| 99 | Papillary thyroid carcinoma (HP:0002895) | 1.44428153 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.44378682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.46270865 |
| 2 | MST4 | 4.03703207 |
| 3 | MYLK | 3.54801620 |
| 4 | BMX | 3.51740243 |
| 5 | BTK | 3.12704342 |
| 6 | TEC | 2.81069045 |
| 7 | PTK2B | 2.64504226 |
| 8 | CSF1R | 2.46853235 |
| 9 | SYK | 2.44942687 |
| 10 | EIF2AK1 | 2.29591740 |
| 11 | ZAP70 | 2.20285082 |
| 12 | BMPR2 | 2.08608945 |
| 13 | FES | 2.00855077 |
| 14 | ILK | 2.00574528 |
| 15 | GRK5 | 1.95705304 |
| 16 | GRK6 | 1.93428346 |
| 17 | BLK | 1.92538702 |
| 18 | FGR | 1.85599929 |
| 19 | MAP4K1 | 1.79253599 |
| 20 | TAOK3 | 1.78038016 |
| 21 | TIE1 | 1.77557224 |
| 22 | MAPKAPK3 | 1.63162258 |
| 23 | PIK3CG | 1.62266752 |
| 24 | HCK | 1.57594440 |
| 25 | MAP2K3 | 1.46352297 |
| 26 | LYN | 1.43204499 |
| 27 | DAPK3 | 1.38625386 |
| 28 | TNK2 | 1.35368915 |
| 29 | CSK | 1.34716625 |
| 30 | KDR | 1.31455263 |
| 31 | IKBKB | 1.30838484 |
| 32 | MATK | 1.17143572 |
| 33 | SIK3 | 1.05794923 |
| 34 | ITK | 1.05668055 |
| 35 | FGFR4 | 1.02275089 |
| 36 | EPHA3 | 0.99910405 |
| 37 | TAOK2 | 0.95137075 |
| 38 | TLK1 | 0.94534030 |
| 39 | PAK1 | 0.93414589 |
| 40 | MAP3K12 | 0.93311754 |
| 41 | ARAF | 0.92186703 |
| 42 | MAPK12 | 0.90316076 |
| 43 | RET | 0.89082449 |
| 44 | JAK1 | 0.88304083 |
| 45 | MARK3 | 0.86076720 |
| 46 | PDK1 | 0.83435928 |
| 47 | EPHB2 | 0.80893182 |
| 48 | IRAK4 | 0.80860375 |
| 49 | JAK3 | 0.79477379 |
| 50 | STK3 | 0.79425889 |
| 51 | PDPK1 | 0.75657239 |
| 52 | ACVR1B | 0.74466504 |
| 53 | NEK9 | 0.74316637 |
| 54 | FER | 0.73235316 |
| 55 | PIM2 | 0.72304272 |
| 56 | STK24 | 0.71799129 |
| 57 | LCK | 0.71185726 |
| 58 | TXK | 0.70087230 |
| 59 | MAP3K5 | 0.69479476 |
| 60 | IRAK1 | 0.69268140 |
| 61 | EPHB1 | 0.67300217 |
| 62 | JAK2 | 0.66739072 |
| 63 | PRKD1 | 0.63125080 |
| 64 | LMTK2 | 0.63078109 |
| 65 | MAP3K3 | 0.62086978 |
| 66 | TYK2 | 0.58647822 |
| 67 | FGFR3 | 0.58001590 |
| 68 | TBK1 | 0.57883922 |
| 69 | MAP3K11 | 0.57368678 |
| 70 | DAPK1 | 0.56777604 |
| 71 | ADRBK2 | 0.55569475 |
| 72 | PLK2 | 0.54208157 |
| 73 | TESK2 | 0.52385599 |
| 74 | ADRBK1 | 0.52144832 |
| 75 | PRKCQ | 0.50974052 |
| 76 | ERBB2 | 0.50889524 |
| 77 | DAPK2 | 0.50641394 |
| 78 | TAOK1 | 0.50178913 |
| 79 | PIM1 | 0.50164660 |
| 80 | PRPF4B | 0.49206194 |
| 81 | PKN1 | 0.48467027 |
| 82 | PRKACG | 0.48462516 |
| 83 | IKBKE | 0.48273134 |
| 84 | YES1 | 0.47880577 |
| 85 | DDR2 | 0.47520157 |
| 86 | PDGFRB | 0.46881273 |
| 87 | FYN | 0.46691563 |
| 88 | MAP3K1 | 0.45246518 |
| 89 | MAP2K1 | 0.44031928 |
| 90 | MAP3K13 | 0.43717855 |
| 91 | MAPK11 | 0.41147527 |
| 92 | MAP3K14 | 0.39445077 |
| 93 | IRAK3 | 0.38449330 |
| 94 | PRKCD | 0.37490206 |
| 95 | BMPR1B | 0.33765804 |
| 96 | HIPK2 | 0.33718020 |
| 97 | IGF1R | 0.33606693 |
| 98 | CDC42BPA | 0.33019289 |
| 99 | SRC | 0.30523094 |
| 100 | PRKG1 | 0.26715857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 4.37590218 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62770318 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.49824369 |
| 4 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.42626315 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.30282009 |
| 6 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.23075760 |
| 7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.13728555 |
| 8 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.96035594 |
| 9 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.94303077 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.81965772 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.81905828 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.80094190 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78430599 |
| 14 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.77103950 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69206716 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63959510 |
| 17 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59881703 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54714322 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53319507 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40226784 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39964929 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35161858 |
| 23 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.28927096 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.26989403 |
| 25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26661284 |
| 26 | Alcoholism_Homo sapiens_hsa05034 | 1.21290278 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21070137 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21014779 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18858152 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16301059 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14945058 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.14592378 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14247922 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12888346 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.08311201 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07577865 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06611354 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05619055 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05448949 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04252523 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04134684 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.03910837 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01059006 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99855372 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98746019 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98503590 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.97247349 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96024523 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95260070 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93776507 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92360287 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90562523 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.89149071 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88791488 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88182405 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86673794 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86177936 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81686423 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81052294 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80322254 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78033398 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77373235 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74564830 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72357275 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72356881 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71797922 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71067174 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.69681672 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67272023 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.66203298 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.65986662 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65911587 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65625568 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60626374 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60163833 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.59126636 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57427809 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57194509 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56235486 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51842674 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.51474822 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50554606 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50519122 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.50275833 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48248808 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.48003127 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47235234 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46655834 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.45900312 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44450145 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.43556518 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43314381 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.43033875 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42304919 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40369584 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39506003 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38977450 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38755239 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36680015 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35787642 |

